Interim report July – September 2019
Third quarter in brief · SyntheticMR had a sales growth of 7% in the third quarter compared to the previous year. · Net sales amounted to SEK 12.0 million (11.2). · Operating profit amounted to SEK 3.4 million (5.4). · Profit for the period amounted to SEK 2.5 million (4.2). · Earnings per share amounted to SEK 0.62 (1.04). · Sales for rolling 12 months amounted to SEK 50.5 million (46.1). Nine months in brief · Net sales amounted to SEK 35.2 million (33.0), which means a sales growth of 7%. · Operating profit amounted to SEK 9.5 million (13.4). · Profit for